Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC)

Historical Holders from Q1 2023 to Q3 2025

Symbol
RNAC on Nasdaq
Type / Class
Equity / COMMON STOCK
Shares outstanding
25,973,289
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
5,968,086
Holdings value
$60,898,831
% of all portfolios
0%
Number of holders
65
Number of buys
26
Number of sells
-24
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SPRINGER TIMOTHY A 36.9% +0.27% $116,671,361 +$258,583 9,555,394 +0.22% Timothy A. Springer 13 Jan 2025
FMR LLC 8.3% -12.2% $22,041,372 -$2,734,285 2,155,783 -11% FMR LLC 30 Sep 2025
JPMORGAN CHASE & CO 6.1% $20,459,516 1,675,636 JPMORGAN CHASE & CO. 31 Mar 2025

Institutional Holders of Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 5,968,086 $60,898,831 -$4,440,064 $10.22 65
2025 Q2 6,401,037 $66,468,780 -$2,049,017 $10.39 65
2025 Q1 6,582,077 $86,710,172 -$755,346 $13.18 68
2024 Q4 6,665,799 $119,478,509 -$2,692,613 $17.91 64
2024 Q3 6,867,968 $110,349,366 +$42,879,892 $16.12 61
2024 Q2 3,268,033 $88,276,427 +$88,059,260 $27.01 57
2024 Q1 1,855 $1,157 +$1,157 $0.6375 4
2023 Q4 0 $0 -$1,272 0
2023 Q3 1,200 $1,272 $1.06 1
2023 Q2 1,200 $1,344 $1.12 1
2023 Q1 1,200 $1,668 +$1,668 $1.39 1